Posts by kforbes

Piedmont Healthcare joins nonprofit generic drug company Civica

Piedmont Healthcare has joined Civica, a new nonprofit generic drug company with a goal of reducing chronic drug shortages in the United States, Piedmont announced Thursday. Launched last year, Civica supplies its members at least 14 drugs commonly used by hospitals in emergency care, surgery, pain management and in treating hypertension. More recently, Civica announced…

Read More

Alimera Announces ILUVIEN® Regulatory Approval in Australia for the Treatment of Diabetic Macular Edema

Aug 5, 2019 Specialised Therapeutics, an Australian biopharmaceutical company and Alimera’s distribution partner, to next seek national reimbursement ATLANTA, Aug. 05, 2019 (GLOBE NEWSWIRE) — Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a leader in the commercialization and development of prescription ophthalmology treatments for the management of retinal diseases, announces today that the Australian Therapeutic Goods Administration (TGA), the division of the Australian…

Read More

ArunA Bio Raises $13 Million in Common Stock Financing

— Financing proceeds to advance ArunA Bio’s neural exosome therapies for neurodegenerative diseases and partnering activities — — ArunA Bio establishes an office in Research Triangle Park, NC — Athens, GA; Research Triangle Park, NC – July 24, 2019—ArunA Bio, Inc., a leader in the development of neural exosomes for the treatment of neurodegenerative diseases,…

Read More

Freenome Closes $160 Million Series B Financing to Advance Its Multiomics Blood Testing Platform for Early Cancer Detection

Proceeds Will Fund Pivotal Validation Study of Company’s Blood-based Test for the Screening of Colorectal Cancer Platform Has Potential for Use in Multiple Cancer Types and Enhanced Drug Development by Characterizing Tumor and Immune Signatures July 24, 2019 09:00 AM Eastern Daylight Time SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Freenome, a biotechnology company that has pioneered the most…

Read More

CenExel Clinical Research Establishes Clinical Trial Centers Of Excellence Company

Unites Four of the Top US Clinical Research Facilities to Reduce Time and Cost for New Drug Development SALT LAKE CITY, July 18, 2019 /PRNewswire/ —  CenExel Clinical Research, Inc., (“CenExel” or the “Company”) announces the creation of their Centers of Excellence company, which unites four of the most experienced clinical research units in the country to design…

Read More

Sharecare names Quest Diagnostics its preferred laboratory partner to advance digital health management

ATLANTA (July 12, 2019) – Sharecare, the digital health company that helps people manage all their health in one place, and Quest Diagnostics (NYSE: DGX) have formed a collaboration designed to improve digital health and disease management for a range of health care consumers. Sharecare has named Quest its preferred laboratory partner for its comprehensive digital…

Read More

Removal of Safe Harbor Protection for Rebates to Plans or PBMs Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection

Washington, D.C. (July 11, 2019) – BIO’s President and CEO Jim Greenwood issued the following statement after it was reported that the Trump administration is withdrawing its proposed rebate rule that would have required savings from drugmakers’ rebates be passed along to seniors enrolled in the Medicare drug benefit program: “The administration has abandoned one of the only…

Read More

BIO Applauds Enactment of the Pandemic and All-Hazards Preparedness and Advancing Innovation Act

Legislation will strengthen pipeline of medical countermeasures against serious public health threats Washington, DC (June 25, 2019) – The Biotechnology Innovation Organization (BIO) today applauds the enactment of the Pandemic and All-Hazards Preparedness and Advancing Innovation (PAHPAI) Act, signed into law by President Trump late yesterday. The law re-authorizes critical federal biodefense programs and agencies, including…

Read More